Noel Goddard

Noel Goddard has a diverse work experience spanning multiple industries and roles. In 2012, Noel founded Goddard Labs and served as the CEO and Founder until 2016. From 2015 to 2018, Noel worked as the Chief Technology Officer at Symbiotic Health, Inc. In 2016, Noel joined Accelerate NY Seed Fund as a Principal and later became a Portfolio Manager until 2022. Additionally, Noel served as a Director of Operations at BioLabs in 2017. In 2019, Noel took on the role of Investment Advisor at The Catalytic Impact Foundation and became a Member of the Board of Advisors at M-Corps / For ClimateTech. From 2019 to 2021, Noel was also a Chief Executive Officer at Qunnect and held the position of Chief Operating Officer from 2020 to 2020. In 2020, Noel became a Board Member at Monogram Orthopaedics. Starting in 2021, Noel took on the role of Mentor at Duality Accelerator and joined HashLynx Inc. as a Board Member until 2022.

Noel Goddard has an extensive education history, starting with their time at The Cooper Union for the Advancement of Science and Art from 1992 to 1994, where they studied Chemical Engineering. They then transferred to New York University - Polytechnic School of Engineering, where they obtained a B.S. degree in Chemistry & Humanities from 1994 to 1996. Following this, they pursued a M.S. degree in Chemical Physics at the same institution from 1996 to 1998. Moving forward, Goddard attended The Rockefeller University from 1999 to 2004, where they earned a Ph.D. degree specializing in Physics & Biology. Finally, from 2004 to 2007, Goddard completed a Postdoctoral Research fellowship as a Junior Fellow at Harvard University, specifically in the Society of Fellows program. The provided information does not specify any specific field of study for their postdoctoral research period at Harvard University.